Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis - Wikidata - awgldk - TriplyDB

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis

http://www.wikidata.org/entity/Q34295921

about

Salubrinal acts as a Dusp2 inhibitor and suppresses inflammation in anti-collagen antibody-induced arthritis Role of miR-222-3p in c-Src-Mediated Regulation of Osteoclastogenesis.Knee loading inhibits osteoclast lineage in a mouse model of osteoarthritis Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesions The WNT system: background and its role in bone.Dental and extra-oral clinical features in 41 patients with WNT10A gene mutations: A multicentric genotype-phenotype study.Suppression of osteoclastogenesis via α2-adrenergic receptors.

P2860

Q35118294-8ADB4F0A-62F0-4533-BCE6-A2D50C7DBE0A Q36667170-1A2B380C-AA63-4C57-85C2-E8D0610A8C97 Q36806408-648D7D32-36F0-48A1-909F-882E784035EB Q37205581-241693CB-F959-4F86-B83A-E0D5C3FA8DFD Q38407357-0941EC36-83CC-4421-A4EA-59ACB59A460C Q48331932-330C445D-D60C-417E-8446-841F5EDDC70A Q55279393-F6F323DF-83A5-48D8-B62F-8510296E6CC0

P2860

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis

http://www.wikidata.org/entity/Q34295921

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis

@ast

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis

@en

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis

@nl

type

label

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis

@ast

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis

@en

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis

@nl

prefLabel

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis

@ast

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis

@en

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis

@nl

P1433

Q34295921-CB461FBE-0830-4B48-991E-920012369B2C

P1476

Q34295921-85EAD6CB-85DB-44F1-9AC5-2034A5BA3150

P2093

Q34295921-69011A15-2C20-4763-8537-981E20B0BC1A

Q34295921-76990B64-D064-466F-B9DA-A887D98D7D68

Q34295921-858CBB5C-33B6-4194-9D84-444D827048A5

Q34295921-B18706DD-5EED-4EF5-801B-4EC9DB3073FC

Q34295921-DE94ACDC-5959-4F77-8B46-B3BF9B43C808

P2860

Q34295921-01A7FC79-FB69-45F9-BDF9-601816F38257

Q34295921-11F5C332-18B1-4407-8C70-B4284CDD30B2

Q34295921-16DC10B9-063B-4C5D-9AB9-42F2441C415E

Q34295921-21729F02-84AA-4F9F-A90F-2A890D0816E4

Q34295921-25753998-33E8-49FB-9E4E-91A6EC051DC8

Q34295921-2A1F020D-C515-4E7A-A65C-6A07A1C544AB

Q34295921-42BC9C62-14FA-45D4-81B0-12A5A9276AE9

Q34295921-432796BB-0C64-4D24-AE5C-7E41BC2DD761

Q34295921-47CD6E97-E9B4-4E6C-A1B7-83123FB2C84C

Q34295921-497F7728-7256-47D2-B3C5-1767CC564949

P304

Q34295921-1E51FD94-2FC8-495E-86CF-75350A01C94F

P31

Q34295921-BDFB627A-4071-471D-A40B-94F238FB938A

P356

Q34295921-435367D9-456B-45EF-BBAD-9660A7DA97EE

P407

Q34295921-9F5CDBA8-AF3D-4C68-A6B2-572A77711B27

P433

Q34295921-05AD8EB6-453B-4478-9691-8D70292198CB

P478

Q34295921-38F366CB-B3A3-4A34-89D5-576A65A62318

P50

Q34295921-9E402E21-CE72-4B68-95E9-7823E2E28200

P577

Q34295921-7F7F1135-BFF0-4015-AAF5-54B68A9DF388

P698

Q34295921-163CEB0F-4972-4425-BE3A-1FF29CFD2FD4

P921

Q34295921-E9C3744C-406B-49A8-AC66-D6A8E1A31F92

P932

Q34295921-D87F619A-A7CB-4D85-B390-68228EF13B78

P356

J.CELLSIG.2014.07.018

P1433

Cellular Signalling

P1476

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis

@en

P2093

Akihiro Sudo

http://www.w3.org/2001/XMLSchema#string

Akinobu Nishimura

http://www.w3.org/2001/XMLSchema#string

Andy Chen

http://www.w3.org/2001/XMLSchema#string

Hiroki Yokota

http://www.w3.org/2001/XMLSchema#string

Nancy Tanjung

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

beta-catenin signaling and cancer

Principal components analysis to summarize microarray experiments: application to sporulation time series

Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis

WNT signaling in bone homeostasis and disease: from human mutations to treatments

Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins

Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

Sox17 modulates Wnt3A/beta-catenin-mediated transcriptional activation of the Lef-1 promoter.

TRANSFAC: transcriptional regulation, from patterns to profiles

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

P304

2358-2369

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELLSIG.2014.07.018

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Kazunori Hamamura

P577

2014-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25038457

http://www.w3.org/2001/XMLSchema#string

P921

P932

4187210

http://www.w3.org/2001/XMLSchema#string